Switch to:
More From Other Websites
Will Gilead (GILD) Miss Earnings on High Operating Costs? Oct 24 2014
Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta Oct 24 2014
Pharmacyclics Up on Label Expansion Efforts for Imbruvica Oct 22 2014
NewLink-Roche Ink Deal for Oncology Candidate Development Oct 21 2014
Can Valeant's Strong Q3 Entice Allergan? Oct 20 2014
Small victories recorded in fight against Ebola Oct 20 2014
Why NewLink Genetics (NLNK) Stock Is Soaring Today Oct 20 2014
Stocks Open Quietly Mixed; Hasbro, NewLink, Akorn Rising Oct 20 2014
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO... Oct 20 2014
Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy Oct 17 2014
Roche Reports Strong Sales Results for 9 Months of 2014 Oct 17 2014
Ohr Pharmaceutical's OHR-102 to Enter Phase III in 1H15 Oct 16 2014
Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® and GAZYVA® in Lymphoma and... Oct 16 2014
Swiss drug maker Roche posts flat 9-month sales Oct 16 2014
Swiss drug maker Roche posts flat 9-month sales Oct 16 2014
F.D.A. Approves First 2 Drugs for Treatment of a Fatal Lung Disease Oct 15 2014
FDA Approves Esbriet® (pirfenidone) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) in the... Oct 15 2014
FDA Approves Competing Lung Disease Drugs From Roche and Boehringer Oct 15 2014
Roche (RHHBY) Progresses with Label Expansion of Lucentis Oct 09 2014
FDA Grants Priority Review for Genentech’s Lucentis in Diabetic Retinopathy Oct 08 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Steve.dunfield@google
ReplySteve.dunfield@google - 6 months ago
Adjust for split?


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK